phosphatidylcholines has been researched along with antimony in 3 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (antimony) | Trials (antimony) | Recent Studies (post-2010) (antimony) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 4,323 | 70 | 1,311 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goyal, AK; More, DK; Murray, HW; Singh, MK; Sundar, S | 1 |
Goyal, AK; Makharia, MK; Mandal, AK; Murray, HW; Singh, VP; Sundar, S | 1 |
Murray, HW | 1 |
1 review(s) available for phosphatidylcholines and antimony
Article | Year |
---|---|
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic | 2004 |
2 trial(s) available for phosphatidylcholines and antimony
Article | Year |
---|---|
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex.
Topics: Adolescent; Adult; Amphotericin B; Analysis of Variance; Antimony; Antiprotozoal Agents; Child; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Female; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Single-Blind Method | 1998 |
Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Antimony; Chi-Square Distribution; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leishmaniasis, Visceral; Male; Phosphatidylcholines; Phosphatidylglycerols; Probability; Treatment Outcome | 1999 |